DEC International
DEC is a leading developer and manufacturer of drug delivery solutions, specializing in controlled release implants, microneedle patches, and other innovative medical devices. With over 40 years of experience, DEC supports its partners from product development through GMP manufacturing, aiming to release the potential of potent drug delivery devices and improve healthcare outcomes globally.
Industries
Nr. of Employees
large (251-1000)
DEC International
Products
Transdermal and intracavitary sustained-release devices
Moulded and extruded silicone or polymeric devices designed to deliver potent actives to mucosal or transdermal sites for sustained release.
Subdermal drug-eluting implants
Long-term implants manufactured by extrusion or moulding to deliver potent actives to local tissues for both local and systemic effects.
Dissolvable microneedle patches
Multi-layer dissolvable microneedle patches produced by moulding and solvent casting for sustained or bolus delivery through the skin.
Gastric/rumen-retentive capsules
High-payload, retention-capable oral/rumen devices designed for long-term delivery, oriented to lower carbon footprint manufacturing.
Transdermal and intracavitary sustained-release devices
Moulded and extruded silicone or polymeric devices designed to deliver potent actives to mucosal or transdermal sites for sustained release.
Subdermal drug-eluting implants
Long-term implants manufactured by extrusion or moulding to deliver potent actives to local tissues for both local and systemic effects.
Dissolvable microneedle patches
Multi-layer dissolvable microneedle patches produced by moulding and solvent casting for sustained or bolus delivery through the skin.
Gastric/rumen-retentive capsules
High-payload, retention-capable oral/rumen devices designed for long-term delivery, oriented to lower carbon footprint manufacturing.
Services
End-to-end contract development and manufacture of sustained-release polymeric and silicone drug-delivery devices from R&D through GMP commercial production.
Product requirement specification development, prototyping and manufacturability guidance to align end-user requirements with scalable production.
Process design using Quality by Design (QbD), DoE screening, automation and process studies to transition from pilot to industrial GMP manufacture.
Development, verification and validation of analytical assays (chromatography, spectroscopy, dissolution), plus GMP raw material, in-process and release testing and stability programmes.
Design and execution of IQ/OQ/PQ, equipment qualification, tool inspections and refurbishment, and pre-production validation in pilot GMP suites.
Transfer of processes and quality testing into GMP suites, preparation of technical files, further qualification/validation at scale, and support for commercial supply logistics.
End-to-end contract development and manufacture of sustained-release polymeric and silicone drug-delivery devices from R&D through GMP commercial production.
Product requirement specification development, prototyping and manufacturability guidance to align end-user requirements with scalable production.
Process design using Quality by Design (QbD), DoE screening, automation and process studies to transition from pilot to industrial GMP manufacture.
Development, verification and validation of analytical assays (chromatography, spectroscopy, dissolution), plus GMP raw material, in-process and release testing and stability programmes.
Design and execution of IQ/OQ/PQ, equipment qualification, tool inspections and refurbishment, and pre-production validation in pilot GMP suites.
Transfer of processes and quality testing into GMP suites, preparation of technical files, further qualification/validation at scale, and support for commercial supply logistics.
Expertise Areas
- Controlled-release drug delivery
- Implantable and transdermal device development
- Microneedle patch manufacture
- Polymer composite formulation and processing
Key Technologies
- Injection moulding
- Twin-screw extrusion
- Co-extrusion
- Solvent casting